BiomX To Present at H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

BiomX Inc. (NYSE American: PHGE), a clinical-stage microbiome company, announced that CEO Jonathan Solomon will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, at 7:00 AM EST. The conference runs from September 12-14, 2022. Presentations will be available on-demand, and the webcasts can be accessed via the BiomX Investors section post-event. The company focuses on developing phage therapies targeting pathogenic bacteria to treat chronic diseases.

NESS ZIONA, Israel--(BUSINESS WIRE)-- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer of BiomX, will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022.

H.C Wainwright Global Investment Conference – September 12-14, 2022
Date & Time:	Monday, September 12, 7:00 AM EST (Available on Demand)
Presenter:	Jonathan Solomon
Conference registration:	Link

Webcasts of presentations will also be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.

About BiomX Inc.

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.biomx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220911005046/en/

BiomX Contacts

Investor Relations:

LifeSci Advisors, LLC

John Mullaly

(617)-698-9253

jmullaly@lifesciadvisors.com

BiomX, Inc.

Anat Primovich

Corporate Project Manager

+972 (50) 697-7228

anatp@biomx.com

Source: BiomX Inc.

FAQ

When is the BiomX presentation at the H.C. Wainwright conference?

BiomX will present on September 12, 2022, at 7:00 AM EST.

Who is presenting for BiomX at the conference?

CEO Jonathan Solomon will present for BiomX at the conference.

What dates does the H.C. Wainwright Global Investment Conference take place?

The conference takes place from September 12 to September 14, 2022.

Where can I watch the BiomX conference presentation?

The presentation will be available on-demand, with webcasts accessible through the BiomX Investors section.

What is BiomX's focus in the healthcare sector?

BiomX focuses on developing natural and engineered phage therapies for targeting pathogenic bacteria in chronic disease treatment.